Korea FilingsFull brief — $39

HYUNDAI BIOSCIENCE CO., LTD.

현대바이오사이언스(주) · KOSDAQ: 048410 · Manufacture of other chemical products

Key facts

Korean name
현대바이오사이언스(주)
Market / ticker
KOSDAQ · 048410
Industry
Manufacture of other chemical products
Established
2000-05-25
Fiscal year ends
December
Website
www.hyundaibioscience.com
DART corp code
00313649
Latest revenue
₩3.5B (FY2025)

Items worth checking

medium
Revenue fell 77% from FY2024 to FY2025.
medium
Decision to issue convertible / warrant / exchangeable bonds — the filing states whether new or treasury shares back it — filed on 2 separate dates in the last 12 months, latest 2026-06-15.

Financial summary

KRWFY2023FY2024FY2025
Revenue₩9.5B₩15.1B₩3.5B
Operating income−₩9.8B₩834M−₩18.2B
Net income−₩14.5B−₩6.9B−₩22.1B
Total assets₩52.8B₩67.7B₩130.7B
Total liabilities₩7.5B₩28.3B₩20.0B
Total equity₩45.3B₩39.4B₩110.7B
Share capital₩19.9B₩19.9B₩48.0B

Consolidated statements · FY2025 operating margin -516.3% · liabilities to equity 18% · Annual report FY2025 (Korean original)

Auditor opinions

PeriodAuditorOpinion
Term 26 (current)삼정회계법인Unqualified
Term 25 (prior)삼정회계법인Unqualified
Term 24 (two years prior)태성회계법인Unqualified

Largest shareholder history

No change history reported in the latest annual report.

Recent filings

DateFilingOriginal
2026-09-08Large shareholding (5%+) reportDART
2026-09-04Material management matterDART
2026-08-13Half-year report (2026.06)DART
2026-08-06Large shareholding (5%+) reportDART
2026-07-22Large shareholding (5%+) reportDART
2026-06-30Large shareholding (5%+) reportDART
2026-06-23Material event reportDART
2026-06-23Securities issuance results (voluntary)DART
2026-06-19Large shareholding (5%+) reportDART
2026-06-15Material event report — Convertible bond issuance decisionDART
2026-06-12Large shareholding (5%+) reportDART
2026-05-29Large shareholding (5%+) reportDART
2026-05-15Quarterly report (2026.03)DART
2026-04-23Large shareholding (5%+) reportDART
2026-04-17Material management matterDART
2026-03-30Amended: Annual report (2025.12)DART
2026-03-26Annual general meeting resultsDART
2026-03-26Large shareholding (5%+) reportDART
2026-03-18Annual report (2025.12)DART
2026-03-17Audit report submittedDART

Showing the 20 most recent of 49 filings. The full brief lists all of them.

Full brief on HYUNDAI BIOSCIENCE CO., LTD. — $39 Get the full brief

For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).

Other Korean companies in Manufacture of other chemical products

Data generated 2026-09-16 from OpenDART.

This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.